Mogy Joel R Investment Counsel Inc. increased its stake in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 43.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 154,684 shares of the company’s stock after purchasing an additional […]